Status:
UNKNOWN
Long Term Sequelae of COVID-19: Follow-up Study in Dhaka, Bangladesh
Lead Sponsor:
International Centre for Diarrhoeal Disease Research, Bangladesh
Collaborating Sponsors:
United States Agency for International Development (USAID)
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
COVID-19 or coronavirus disease 2019 is an emerging infectious disease. The disease was first identified in China and then spread worldwide; hence, declared as a global pandemic on March 11, 2020 by W...
Detailed Description
Coronavirus disease 2019 (COVID-19) is caused by a novel coronavirus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). From December 2019, it has rapidly spread across China and ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Age ≥ 18 years
- Participants categorized as mild, moderate and severe/critical disease according to the classification of WHO and the national guideline on COVID-19 case management published by the DGHS \[28\], Bangladesh and discharged from the hospital or outpatient clinic
- Participants residing within Dhaka city corporation area
- Willing to participate in this study
- Exclusion criteria:
- Participants will be excluded if they have a history mental illness before COVID-19
- Participants with RT-PCR-confirmed SARS-CoV-2 infections but without any relevant clinical symptoms in the preceding fourteen days will be excluded.
- Participants residing outside the Dhaka city corporation area and not willing to participate in the study
- Inclusion criteria for comparison group:
- Same as exposed group except that they are not exposed to SARS-CoV-2 infection as evident by negative RT-PCR test. Other criteria for comparison group are given below.
- Participants will be included if the RT-PCR test is negative during enrollment
- Age ≥ 18 years
- Participants residing within Dhaka city corporation area
- Willing to participate in this study
- Exclusion criteria for comparison group:
- • Participants with any known co morbidities including obesity will be excluded
Exclusion
Key Trial Info
Start Date :
February 8 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 4 2022
Estimated Enrollment :
398 Patients enrolled
Trial Details
Trial ID
NCT05242185
Start Date
February 8 2021
End Date
April 4 2022
Last Update
April 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ICDDR,B
Dhaka, Bangladesh, 1212